Tardive dyskinesia and psychotropic drug history

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Psychopharmacology

• Publication date

  1978-07-06

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF00426893PMID 28544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tardive dyskinesia syndrome.

  1978cited by this paper
• The Mitten pattern as a potential EEG predictor of tardive dyskinesia [proceedings].

  1978cited by this paper
• The tardive dyskinesia syndrome.

  1978cited by this paper
• Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.

  1977cited by this paper
• A survey of tardive dyskinesia in psychiatric outpatients.

  1977cited by this paper
• Epidemiology of tardive dyskinesia: I.

  1976cited by this paper
• Epidemiology of tardive dyskinesia Part I.

  1976cited by this paper
• Comparative Analysis of Persistent Dyskinesias of Long‐Term Usage With Neuroleptics in France and in Japan

  1975cited by this paper
• Letter: Deanol for tardive dyskinesia.

  1975cited by this paper
• Tardive dyskinesia and drug therapy in geriatric patients.

  1974cited by this paper
• Neurological consequences of psychotropic drug withdrawal in schizophrenic children

  1973cited by this paper
• ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA

  1973cited by this paper
• Neurologic syndromes associated with antipsychotic-drug use.

  1973cited by this paper
• Persistent Dyskinesia

  1973cited by this paper
• Antiparkinson drugs as causal agents in tardive dyskinesia.

  1973cited by this paper
• The prevalence of tardive dyskinesias in mental hospital patients.

  1972cited by this paper
• Tardive Dyskinesia: Its Relation to Neuroleptic and Antiparkinson Drugs

  1972cited by this paper
• Extrapyramidal Disorders After Prolonged Phenothiazine Therapy

  1971cited by this paper
• The Significance of Brain Damage in Persistent Oral Dyskinesia

  1970cited by this paper
• High doses of trifluperazine and tardive dyskinesia.

  1970cited by this paper
• Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).

  1968cited by this paper
• Persistent Oral Dyskinesia in Female Mental Hospital Patients

  1966cited by this paper
• AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.

  1964cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMAGOTHERAPY OF PSYCHOSES

  1964cited by this paper
• NEUROLOGICAL SYMPTOMS IN PHARMACOTHERAPY OF PSYCHOSES.

  1964cited by this paper

• Tardive Dyskinesia: 21st Century May Bring New Treatments to a Forgotten Disorder

  2017cites this paper
• Identification and management of tardive dyskinesia: A case series and literature review

  2015cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Psychiatric Correlates of the B-Mitten EEG Pattern

  2013cites this paper
• Early dyskinesia — vulnerability

  2005cites this paper
• Tardive dyskinesia in non-western countries: A review

  2005cites this paper
• Cytotoxic effects of neuroleptic drugs

  2004cites this paper
• Serum neuroleptic concentrations and tardive dyskinesia

  2004cites this paper
• A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines

  2004cites this paper
• Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: Relationship to dose and drug

  2004cites this paper
• Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice.

  2002cites this paper
• Women and Drugs: A New Era for Research, 65

  2002cites this paper
• Insomnia related to biperiden withdrawal in two schizophrenic patients.

  2000cites this paper
• Modulation of Brain Dopamine Transmission by Sex Steroids

  1994cites this paper
• Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs.

  1993cites this paper
• Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens.

  1992cites this paper
• Relationship of symptomatology of schizophrenia and tardive dyskinesia.

  1992cites this paper
• Tardive dyskinesia in elderly psychiatric patients: a 5-year study.

  1992cites this paper
• Gender differences in tardive dyskinesia: a critical review of the literature.

  1992cites this paper
• Factors in the development of severe forms of tardive dyskinesia.

  1990cites this paper
• Tardive Dyskinesia: a Five Year Follow-Up*

  1989cites this paper
• Pharmacy-Based Screening Program for Tardive Dyskinesia

  1988cites this paper
• The prevalence of tardive dyskinesia in fluphenazine-treated patients.

  1988cites this paper
• Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

  1988cites this paper
• CT abnormalities in tardive dyskinesia.

  1988cites this paper
• Early versus late onset psychosis and tardive dyskinesia.

  1986cites this paper
• Tardive dyskinesia in schizophrenics under 60 years of age.

  1986cites this paper
• Tardive dyskinesia: a concern for the pediatrician.

  1986cites this paper
• An update on tardive dyskinesia.

  1986cites this paper
• Immunogenetic markers in chlorpromazine-induced tardive dyskinesia.

  1986cites this paper
• Effects of estrogen on the basal ganglia.

  1986cites this paper
• Tardive Dyskinesia in Schizophrenics 60 Years of Age under

  1986cites this paper
• Clinical and epidemiologic aspects of tardive dyskinesia.

  1985cites this paper
• Biophysical alterations in cell membranes associated with psychotherapeutic drug exposure, psychopathology, and aging.

  1985cites this paper
• Tardive Dyskinesia: Developmental Factors *

  1985cites this paper
• Tardive dystonia and severe tardive dyskinesia

  1985cites this paper
• Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.

  1985cites this paper
• Preliminary report: voiceprint analysis in tardive dyskinesia.

  1985cites this paper
• Tardive dyskinesia and the primary psychiatric diagnosis

  1984cites this paper
• Tardive Dyskinesia and EEG

  1984cites this paper
• Incidence of tardive dyskinesia in an outpatient population.

  1984cites this paper
• Tardive dyskinesia

  1984cites this paper
• Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.

  1984cites this paper
• Fluspirilene Neuroleptic Depot Injections and Indurations*

  1983cites this paper
• Prevalence of tardive dyskinesia in affective disorder patients.

  1983cites this paper
• Tardive Dyskinesia in an Outpatient Population: Prevalence and Predisposing Factors*

  1983cites this paper
• [Tardive dyskinesia--review of clinic, pathogenesis, prevention and treatment of a late neuroleptic side effect].

  1983cites this paper
• Tardive dyskinesia and anticholinergic drugs.

  1983cites this paper
• A Long Term Prospective Study of Electroencephalographic and Neuropsychological Correlates of Tardive Dyskinesia: Initial Findings at Five Year Follow-Up

  1983cites this paper
• [Tardive dyskinesia: clinical picture, prevalence, and pathophysiology].

  1983cites this paper
• Management of Tardive Dyskinesia: Current Update

  1982cites this paper
• Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables

  1982cites this paper
• Tardive dyskinesia: prevalence and risk factors, 1959 to 1979

  1982cites this paper
• Prevalence of tardive dyskinesia in 3140 French inpatients.

  1982cites this paper
• Familial occurrence of tardive dyskinesia.

  1981cites this paper
• Changing epidemiology of tardive dyskinesia: an overview.

  1981cites this paper
• The Schizophrenia Syndrome: Examples of Biological Tools for Subclassification

  1981cites this paper
• Changes in prevalence, severity, and recovery in tardive dyskinesia with age.

  1980cites this paper
• Prevalence of tardive dyskinesia in an outpatient population.

  1980cites this paper
• Strategy for the study of patients at high risk for tardive dyskinesia.

  1980cites this paper
• Tardive dyskinesia.

  1980cites this paper
• Tardive dyskinesia on Hungarian psychiatric wards.

  1980cites this paper
• The Use of Psychiatric Drugs for Decades

  1980cites this paper
• Tardive dyskinesia: clinical, biological, and pharmacological perspectives.

  1980cites this paper
• Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs.

  1980cites this paper
• What is the best maintenance dose of neuroleptics in schizophrenia?

  1980cites this paper
• Tardive Dyskinesia and Hospital Discharge

  1980cites this paper
• Research as an impetus to improved treatment.

  1980cites this paper